Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SeaStar Medical Holding CorpICU · Entity 7863 | Director | April 12, 2024 | April 16, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SeaStar Medical Holding Corp
Report date April 12, 2024 · Filed April 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 40,300 |
Reported balance
After 2024-04-12 transaction · row 1
1 source rowRow 1 · 2024-04-12 · Grant · Acquired 32,322 · Balance 40,300 F1: Represents a grant of shares of common stock, $0.0001 par value, of the Issuer (the "Common Stock") in lieu of a portion of the cash fees due to the Reporting Person for services as a director of the Issuer. Such shares are fully vested upon issuance. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of shares of common stock, $0.0001 par value, of the Issuer (the "Common Stock") in lieu of a portion of the cash fees due to the Reporting Person for services as a director of the Issuer. Such shares are fully vested upon issuance.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 12, 2024 Filed Apr 16, 2024 19:02 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 per share | 32,322 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-24-001498 · form4.xml · nonDerivative · entry 1 Lobo Andres · CIK 0001949731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,300 F1 · shares: Represents a grant of shares of common stock, $0.0001 par value, of the Issuer (the "Common Stock") in lieu of a portion of the cash fees due to the Reporting Person for services as a director of the Issuer. Such shares are fully vested upon issuance. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 21:09 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantStock Option (Right to Buy) · Derivative | 11,967 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0000929638-23-001147 · form4.xml · derivative · entry 2 Lobo Andres · CIK 0001949731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,967 Underlying: Common Stock · 11,967 shares Expires 2033-04-06 F2 · derivative.exercise_date: All options reported herein will vest, subject to continued service, on the first anniversary of the date of grant. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 21:09 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 per share | 7,978 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-23-001147 · form4.xml · nonDerivative · entry 1 Lobo Andres · CIK 0001949731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,978 F1 · shares: Represents the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest on the first anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.